Cited by 167

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Lipoproteins in the Central Nervous System

LADU, MARY JO, REARDON, CATHERINE, VAN ELDIK, LINDA, FAGAN, ANNE M., BU, GUOJUN, HOLTZMAN, DAVID, GETZ, GODFREY S.·2000·Annals of the New York Academy of Sciences

Abstract

A bstract: Although the synthesis and metabolism of plasma lipoproteins are well characterized, little is known about lipid delivery and clearance within the central nervous system (CNS). Our work has focused on characterizing the lipoprotein particles present in the cerebrospinal fluid (CSF) and the nascent particles secreted by astrocytes. In addition to carrying lipids, we have found that β‐amyloid (Ab) associates with lipoproteins, including the discoidal particles secreted by cultured astrocytes and the spherical lipoproteins found in CSF. We believe that association with lipoproteins provides a means of transport and clearance for Aβ. This process may be further influenced by an interaction between Ab and apoprotein E (apoE), the primary protein component of CNS lipoproteins. Specifically, we have investigated the formation and physiologic relevance of a SDS‐stable complex between apoE and Aβ. In biochemical assays, native apoE2 and E3 (associated with lipid particles) form an SDS‐stable complex with Ab that is 20‐fold more abundant than the apoE4:Aβ complex. In cell culture, native apoE3 but not E4 prevents Aβ‐induced neurotoxicity by a mechanism dependent on cell surface apoE receptors. In addition, apoE and the inhibition of apoE receptors prevent Aβ‐induced astrocyte activation. Therefore, we hypothesize that the protection from Aβ‐induced neurotoxicity afforded by apoE3 may result from clearance of the peptide by SDS‐stable apoE3:Aβ complex formation and uptake by apoE receptors.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.2000.tb06365.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 14 references

Research works printed but not linked: 43

  1. Li W‐H., 1988, The apolipoprotein multigene family: biosynthesis, structure, structure‐function relationships, and evolution, J. Lipid Res., 29, 245, 10.1016/S0022-2275(20)38532-1 · DOI
  2. 10.1097/00005072-199604000-00012 · DOI · Paper page
  3. Kim D.H., 1996, Human apoprotein E receptor 2, A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem., 271, 8373
  4. Silva H.V., 1990, A 70‐kDa apoprotein designated apoJ is a marker for sub‐classes of human plasma high density lipoproteins, J. Biol. Chem., 265, 13240, 10.1016/S0021-9258(19)38290-0 · DOI
  5. 10.1073/pnas.76.9.4646 · DOI · Paper page
  6. 10.1016/S0021-9258(18)47945-8 · DOI · Paper page
  7. 10.1016/0896-6273(93)90070-8 · DOI · Paper page
  8. 10.1074/jbc.271.14.8373 · DOI · Paper page
  9. 10.1097/00005072-199604000-00012 · DOI · Paper page
  10. 10.1074/jbc.270.22.13070 · DOI
  11. 10.1073/pnas.93.9.4229 · DOI · Paper page
  12. 10.1006/exnr.1997.6710 · DOI
  13. 10.1007/BF02591657 · DOI
  14. Smith K.M., 1990, Cellular localization of apolipoprotein D and lecithin: cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization, J. Lipid Res., 31, 995, 10.1016/S0022-2275(20)42739-7 · DOI
  15. 10.1016/0166-2236(92)90190-J · DOI
  16. 10.1016/0166-2236(94)90156-2 · DOI
  17. 10.1073/pnas.90.5.1977 · DOI · Paper page
  18. 10.1111/j.1749-6632.1996.tb34431.x · DOI
  19. 10.1016/S0140-6736(95)91411-0 · DOI
  20. 10.1016/S0003-4975(97)00757-1 · DOI
  21. Slooter A.J.C., 1997, Apolipoprotein E epsilon‐4 and the risk of dementia with stroke‐a population based investigation, J. Am. Med. Assoc., 277, 818, 10.1001/jama.1997.03540340052032 · DOI
  22. 10.1002/ana.410420417 · DOI
  23. Hammad S.M., 1997, Interaction of apolipoprotein J‐amyloid beta‐peptide complex with low density lipoprotein receptor‐related protein‐2/megalin, A mechanism to prevent pathological accumulation of amyloid beta peptide. J. Biol. Chem., 272, 18644
  24. 10.1016/0006-8993(91)91092-F · DOI · Paper page
  25. 10.1007/BF00296787 · DOI · Paper page
  26. 10.1074/jbc.270.13.7563 · DOI · Paper page
  27. 10.1074/jbc.270.16.9039 · DOI · Paper page
  28. 10.1073/pnas.92.3.763 · DOI · Paper page
  29. 10.1038/ng0996-55 · DOI · Paper page
  30. 10.1523/JNEUROSCI.18-01-00195.1998 · DOI · Paper page
  31. 10.1006/bbrc.1996.0940 · DOI
  32. 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H · DOI
  33. 10.1046/j.1471-4159.1997.68020721.x · DOI · Paper page
  34. 10.1016/S0021-9258(18)87014-4 · DOI · Paper page
  35. Innerarity T.L.et al.1986. Type III hyperlipoproteinemia: a focus on lipoprotein receptor‐apolipoprotein E2 interactions. In Advances in Experimental Medicine and Biology. A. Angel & J. Frohlich Eds.: 273–288. Plenum Press. New York. · DOI
  36. 10.1073/pnas.92.21.9480 · DOI · Paper page
  37. 10.1074/jbc.270.45.27063 · DOI · Paper page
  38. 10.1016/0092-8674(95)90320-8 · DOI · Paper page
  39. 10.1002/ana.410370212 · DOI · Paper page
  40. 10.1212/WNL.49.1.56 · DOI · Paper page
  41. 10.1038/1243 · DOI · Paper page
  42. 10.1046/j.1471-4159.1998.71041626.x · DOI · Paper page
  43. 10.1073/pnas.95.26.15598 · DOI

Cited by

Sorted by citations

See all 167

Metadata

Authors
LADU, M. J., REARDON, C., VAN ELDIK, L., FAGAN, A. M., BU, G., HOLTZMAN, D., & GETZ, G. S.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2000-04
Volume
903
Issue
1
Pages
167-175
ISSN
  • 0077-8923
  • 1749-6632
Cited by
167
References
14
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review